Tango Therapeutics, Inc. (TNGX) Stock Overview
Explore Tango Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Tango Therapeutics, Inc. (TNGX)
Key Financials
Key Financials
Market Cap
3.6B
P/E Ratio
-41.18
EPS (TTM)
$-0.83
ROE
-0.42%
TNGX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Tango Therapeutics, Inc. (TNGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 66.19, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $16.09.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -41.18 and a market capitalization of 3.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.